Biogen

BIIB

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.

Biogen has been a target of short sellers for a while. The current short interest of 3.72% is roughly at the average of the last 12 months (3.51%).